Ondansetron: reasons to be restrictive.
Frigerio
C
C
Buchwalder
P A
PA
Spertini
F
F
D000328:Adult; D000707:Anaphylaxis / Q000139:chemically induced*; D000932:Antiemetics / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D008297:Male; D017294:Ondansetron / Q000008:administration & dosage / Q000009:adverse effects*; D012702:Serotonin Antagonists / Q000008:administration & dosage / Q000009:adverse effects*
D000932:Antiemetics; D012702:Serotonin Antagonists; D017294:Ondansetron